|
ADVM
|
Adverum Biotechnologies, Inc.
|
US
|
NASDAQ
|
|
ADXS
|
Advaxis Inc
|
US
|
OTC
|
|
ADYX
|
Adynxx Inc
|
US
|
OTC
|
|
AERI
|
Aerie Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AEZS
|
AEterna Zentaris Inc.
|
US
|
NASDAQ
|
|
AFFY
|
Affymax
|
US
|
OTC
|
|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
AGE
|
AgeX Therapeutics, Inc.
|
US
|
AMEX
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
AGH
|
Althea Group Holdings Limited
|
AU
|
ASX
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AGLE
|
Aeglea BioTherapeutics, Inc.
|
US
|
NASDAQ
|
|
AGRX
|
Agile Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AGTC
|
Applied Genetic Technologies Corporation
|
US
|
NASDAQ
|
|
AGW0
|
ALGERNON PHARMACEUT. A
|
DE
|
F
|
|
AGY
|
Allergy Therapeutics Plc
|
UK
|
LSE
|
|
AIM
|
AIM ImmunoTech Inc.
|
US
|
AMEX
|
|
AIMDW
|
Ainos Inc.
|
US
|
US
|
|
AKBA
|
Akebia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|